IL1B and achalasia-alacrima syndrome: Interleukin-1β (IL-1β) represents a gatekeeper for inflammation and contributes substantially to the progressive destruction of aortic ECM proteins during AAA development.8 Different preclinical and clinical studies demonstrated significantly increased levels of IL-1β in AAAs compared to healthy aortas.